Delivery Order SPE2DB22D3401-SPE2DB25FT6KA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 mL) under a firm fixed price contract valued at $11,884.18. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a $2,953.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,443.00 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) with a firm fixed price structure. The contract is unclassified with no set-aside designation and was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency awarded a delivery order valued at $24,953.40 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe 1.5ml format. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded without set-aside designation. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $31,634 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on September 29, 2025, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,383.30 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6KADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) valued at $12,491.82 under a firm fixed price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and the performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. This contract represents a child delivery order executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies, including vaccines, to support military healthcare programs worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 9/22/25 |